Search
Ticagrelor
go.drugbank.com/drugs/DB08816ApprovedInvestigational[A2903] Unlike [clopidogrel], ticagrelor is not a prodrug.[A2903] It is marketed by Astra Zeneca as Brilinta in the US[L14201] and Brilique or Possia in the EU,[L14207]. … Ticagrelor was granted EMA approval on 3 December 2010.[L14207] Ticagrelor was granted FDA approval on 20 July 2011.[L14201]
Categories: P-glycoprotein inhibitors, P-glycoprotein substratesSynonyms: (1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diolCabergoline
go.drugbank.com/drugs/DB00248ApprovedInvestigationalCabergoline, an ergot derivative, is a long-acting dopamine agonist and prolactin inhibitor. It is used to treat hyperprolactinemic disorders and Parkinsonian Syndrome. … Cabergoline possesses potent agonist activity on dopamine D2 receptors.
Categories: Serotonin 5-HT1 Receptor Agonists, Serotonin 5-HT2 Receptor AgonistsSynonyms: (8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide, (8β)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One
go.drugbank.com/drugs/DB01884ExperimentalSynonyms: 2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-OnePeginterferon alfacon-1
go.drugbank.com/drugs/DB05860Experimental[Infergen] is a bio-engineered type I interferon alpha that is FDA-approved for the treatment of patients with chronic hepatitis C infections. … PEGylation is a technology for the chemical attachment of polyethylene glycol (PEG) polymer chains to a broad range of drug substances such as peptides and proteins including antibody fragments; small
Synonyms: PEG INF alfacon-1, Peginterferon alfacon-1Streptococcus pneumoniae type 5 capsular polysaccharide diphtheria CRM197 protein conjugate antigen
go.drugbank.com/drugs/DB10295ApprovedInvestigationalserotype 5 individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of *Corynebacterium diphtheriae* strain C7 (β197). … Streptococcus pneumoniae type 5 capsular polysaccharide diphtheria CRM197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of *Streptococcus pneumoniae*
Mixtures: PREVENAR 13/0,5 ML IM ENJEKSIYON ICIN SUS. ICEREN KUL.HAZIR ENJEKTOR, 50 ADET, PREVENAR 13/0,5 ML IM ENJEKSIYON ICIN SUS. ICEREN KUL.HAZIR ENJEKTOR, 10 ADETSynonyms: Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine, Streptococcus pneumoniae type 5 capsular polysaccharide diphtheria CRM197 protein conjugate antigenVXA-CoV2-1
go.drugbank.com/drugs/DB16433InvestigationalVXA-CoV2-1 is a non-replicating adenoviral vector-based oral tableted vaccine candidate that expresses a SARS-CoV-2 antigen and dsRNA adjuvant[L30493]. … This oral vaccine aims to induce immunogenicity through induction of potent serum neutralizing antibodies to the SARS-CoV-2 spike protein, induction of mucosal immune responses, and induction of T-cell
P1-(adenosine-5'-P5-(uridine-5')pentaphosphate
go.drugbank.com/drugs/DB03664ExperimentalSynonyms: P1-(adenosine-5'-P5-(uridine-5')pentaphosphate5'-S-[2-(decylamino)ethyl]-5'-thioadenosine
go.drugbank.com/drugs/DB07413ExperimentalSynonyms: 5'-S-[2-(decylamino)ethyl]-5'-thioadenosine1-naphthaleneacetic acid
go.drugbank.com/drugs/DB01750InvestigationalSynonyms: 1-Naphthylacetic acid, naphthalene-1-acetic acid